154 related articles for article (PubMed ID: 27788484)
1. Association of Vitamin D receptor Fok I polymorphism with the risk of prostate cancer: a meta-analysis.
Kang S; Zhao Y; Liu J; Wang L; Zhao G; Chen X; Yao A; Zhang L; Zhang X; Li X
Oncotarget; 2016 Nov; 7(47):77878-77889. PubMed ID: 27788484
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphism of vitamin D receptor gene FokI and susceptibility of prostatic cancer: a meta-analysis].
Cao J; Li X; Hou Q; Li R; Luo R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1215-20. PubMed ID: 23281374
[TBL] [Abstract][Full Text] [Related]
3. Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.
Wang K; Wu G; Li J; Song W
BMC Cancer; 2016 Aug; 16(1):674. PubMed ID: 27553621
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies.
Huang J; Xie ZF
J Neurol Sci; 2012 Feb; 313(1-2):79-85. PubMed ID: 22029942
[TBL] [Abstract][Full Text] [Related]
5. Association of vitamin D receptor gene polymorphisms with prostate cancer risk in the Pakistani population.
Yousaf N; Afzal S; Hayat T; Shah J; Ahmad N; Abbasi R; Ramzan K; Jan R; Khan I; Ahmed J; Siraj S
Asian Pac J Cancer Prev; 2014; 15(22):10009-13. PubMed ID: 25520061
[TBL] [Abstract][Full Text] [Related]
6. [Association of single nucleotide polymorphism of vitamin D receptor gene start codon and the susceptibility to prostate cancer in the Han nationality in Hubei area].
Yang Y; Wang S; Ye Z; Yang W
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):411-4. PubMed ID: 15267201
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
[TBL] [Abstract][Full Text] [Related]
8. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
Smolders J; Damoiseaux J; Menheere P; Tervaert JW; Hupperts R
J Neuroimmunol; 2009 Feb; 207(1-2):117-21. PubMed ID: 19178954
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke.
Prabhakar P; Majumdar V; Kulkarni GB; Christopher R
Biochem Biophys Res Commun; 2015 Jan; 456(2):631-6. PubMed ID: 25498546
[TBL] [Abstract][Full Text] [Related]
10. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
[TBL] [Abstract][Full Text] [Related]
15. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
16. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
Mittal RD; Manchanda PK; Bhat S; Bid HK
BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
[TBL] [Abstract][Full Text] [Related]
17. Association of vitamin D receptor gene polymorphism with the risk of sepsis: A systematic review and meta-analysis.
Li Q; Li W; Chen M; Chai Y; Guan L; Chen Y
Medicine (Baltimore); 2023 Sep; 102(38):e35130. PubMed ID: 37746941
[TBL] [Abstract][Full Text] [Related]
18. The association between FOK-I vitamin D receptor gene polymorphisms and bone mineral density in patients with systemic lupus erythematosus.
Jacobs J; Voskuyl AE; Korswagen LA; Theunissen R; Cohen Tervaert JW; Bultink IE
Clin Exp Rheumatol; 2015; 33(5):765. PubMed ID: 26394116
[No Abstract] [Full Text] [Related]
19. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.
Serrano D; Gnagnarella P; Raimondi S; Gandini S
Eur J Cancer Prev; 2016 Jan; 25(1):85-96. PubMed ID: 25738688
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population.
Ban Y; Taniyama M; Ban Y
J Clin Endocrinol Metab; 2000 Dec; 85(12):4639-43. PubMed ID: 11134121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
